Cipla Global Highlights

Cipla Global Highlights

-
inhalers
#2

Ranked in sale of inhalers globally

Source: Cipla Annual Report 2022-23

-
Aerosol pMDI
125 Million

Aerosol pMDI units produced

-
Nasal spray
48 Million

Nasal spray units produced

-
Respule
773 Million

Respule units produced

-
Tablets
30 Billion

Tablets and capsule produced

read-more-arrow
read-more-arrow